Posted by Michael Wonder on 19 May 2020
Trump admin taps startup to build nation's first stockpile of key drug ingredients
19 May 2020 - The $354 million project is designed to shore up the drug supply chain and reduce the country's dependence on foreign manufacturers.
Seeking to secure the nation's supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation's first strategic stockpile of key ingredients needed to make medicines.
The agreement was signed Monday with Phlow, a generic drug maker based in Virginia. According to a news release to be made public Tuesday, the project will use federal funds from the Biomedical Advanced Research and Development Authority under the Department of Health and Human Services.
